PPT-Why Do We Treat Obesity?
Author : mitsue-stanley | Published Date : 2018-10-29
OrganSpecific Hormonal and Biomechanical Complications Gallbladder Disease OrganSpecific Hormonal and Biomechanical Complications 3 The Paradox of Obesity and
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Why Do We Treat Obesity?" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Why Do We Treat Obesity?: Transcript
OrganSpecific Hormonal and Biomechanical Complications Gallbladder Disease OrganSpecific Hormonal and Biomechanical Complications 3 The Paradox of Obesity and Gallbladder Disease Effect of Obesity. Obesity causes at least 111000 deaths per year in the United States and some researchers place that number at over 400000 Add to these figures the cases of cancer and heart diseasebrought on or worsened by obesityand the cases of type 2 diabetes cau Advanced . English 10. What is Obesity?. Obesity: condition factoring because of excessive body fat. Being 20% above your following age, height, and weight range (BMI) is considered obese. In America 30-35% of the population is obese. Gastro esophageal Reflux Disease. (GERD) . Side Question: What Causes GERD. Side Question 2: How do you treat GERD. By: Devin Montague. Why I chose it: I chose it because I was diagnosed with GERD 4 years ago . Metabolic Complications. 2. Diabetes Risk. Metabolic Complications of Obesity. 3. HDL-C = high-density lipoprotein cholesterol.. Grundy SM, et al. . Circulation.. 2005;112:27-35-2752.. 4. Criteria for Diagnosis of the Metabolic Syndrome. Weight Loss Medications. 2. 3. Phentermine. 4. DEA = Drug Enforcement Agency; T2D = type 2 diabetes.. Adipex-P prescribing information. Sellersville, PA: Teva Pharmaceuticals.; 2013.. 15, 30, or 37.5 mg once daily before breakfast or 1-2 hours after breakfast. Genes, Energy intake . and Adiposity in Early . Life: . preliminary results . from CHILD and START cohorts. Marie . Pigeyre. Post-doc . fellow. (. work. . supervised. by Dr D. . Meyre. ). Plan. Introduction. Weight Loss Medications. 2. 3. Phentermine. 4. DEA = Drug Enforcement Agency; T2D = type 2 diabetes.. Adipex-P prescribing information. Sellersville, PA: Teva Pharmaceuticals.; 2013.. 15, 30, or 37.5 mg once daily before breakfast or 1-2 hours after breakfast. and . cesarean section . . Birth by the Numbers. Gene Declercq. March, 2016. Long Standing Concern with Maternal Obesity. Contemporary . Categorization . of Obesity. BirthByTheNumbers.org. BMI & Obesity Categories. no longer considered a cosmetic issue . that is caused by overeating and a lack of self-control. . The World Health Organization (. W.H.O.), . along with National and International medical and scientific societies, now recognize obesity as . R. . Armour. . Forse. and Devi . Mukkai. . Krishnamurty. ASMBS. 33 % of the world’s population of 7.08 billion— 2.36 billion people—are overweight or obese.. In 2008, more than 1.4 billion adults were overweight and of these more than 200 million men and nearly 300 million women were obese . 1. . Metabolically unhealthy obese (MUO) individuals exhibit obesity-related metabolic abnormalities, while metabolically healthy obese (MHO) individuals do not. 2. . Controversy exists over whether the MHO classification is a transient state that occurs prior to metabolic disease development or if . PwO. ?. Dror Dicker. 1. , Assim Alfadda. 2. , Ian Caterson. 3. , Walmir Coutinho. 4. , Ada Cuevas. 5. , Jason CG Halford. 6. , Carly Hughes. 7. , Masato Iwabu. 8. , Jae-Heon Kang. 9. , Rita Nawar. 10. Survey . Ellen Govers, RD, . NWG (Nutrition . working. . group. EASO/EFAD). 1. Nutrition . Working. Group. What. is the NWG. Commitment . for. Platform Diet, Physical Activity and Health. Phase. Obesity. is a . medical condition. in which excess . body fat. has accumulated to the extent that it may have a negative effect on health, leading to reduced . life expectancy. and/or increased health problems..
Download Document
Here is the link to download the presentation.
"Why Do We Treat Obesity?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents